Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
Current Topics in Medicinal Chemistry|March 7, 2006
Estrogen-related receptors as emerging targets in cancer and metabolic disordersEric A Ariazi, V Craig Jordan
The Lancet. Oncology|June 18, 2002
The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulatorsRuth M O'Regan, V Craig Jordan
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Advances in endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Minerva Endocrinologica|April 19, 2002
Tamoxifen, raloxifene and the prevention of breast cancerD J Bentrem, V Craig Jordan
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
The evolving role of endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Current Opinion in Obstetrics & Gynecology|January 22, 2002
Role of antiestrogens and aromatase inhibitors in breast cancer treatmentDavid J Bentrem, V Craig Jordan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
The estrogen receptor: a model for molecular medicineElwood V Jensen, V Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Problems with the progesterone receptor in practice?V Craig Jordan, Richard D Gelber
Critical Reviews in Oncology/Hematology|April 20, 2004
The biological role of estrogen receptors alpha and beta in cancerSandra Timm Pearce, V Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2007
Selective estrogen-receptor modulators and antihormonal resistance in breast cancerV Craig Jordan, Bert W O'Malley
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Current Topics in Medicinal Chemistry|March 7, 2006
Estrogen-related receptors as emerging targets in cancer and metabolic disordersEric A Ariazi, V Craig Jordan
The Lancet. Oncology|June 18, 2002
The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulatorsRuth M O'Regan, V Craig Jordan
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Advances in endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Minerva Endocrinologica|April 19, 2002
Tamoxifen, raloxifene and the prevention of breast cancerD J Bentrem, V Craig Jordan
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
The evolving role of endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Current Opinion in Obstetrics & Gynecology|January 22, 2002
Role of antiestrogens and aromatase inhibitors in breast cancer treatmentDavid J Bentrem, V Craig Jordan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
The estrogen receptor: a model for molecular medicineElwood V Jensen, V Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Problems with the progesterone receptor in practice?V Craig Jordan, Richard D Gelber
Critical Reviews in Oncology/Hematology|April 20, 2004
The biological role of estrogen receptors alpha and beta in cancerSandra Timm Pearce, V Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2007
Selective estrogen-receptor modulators and antihormonal resistance in breast cancerV Craig Jordan, Bert W O'Malley
Pageof 22